Literature DB >> 11986127

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.

Marc J Mentis1, Anthony R McIntosh, Kenneth Perrine, Vijay Dhawan, Brian Berlin, Andy Feigin, Christine Edwards, Paul Mattis, David Eidelberg.   

Abstract

OBJECTIVE: A multivariate analysis of baseline brain metabolism was used to investigate the relationships among pathophysiological mechanisms responsible for cognitive dysfunction and dysphoria in nondemented patients with Parkinson's disease.
METHOD: Using [(18)F]fluorodeoxyglucose positron emission tomography and neuropsychological tests, the authors studied 15 nondemented patients who had Parkinson's disease without major depression (DSM-III-R). Their mean age was 59.2 years (SD=9.2), the mean rating of Parkinson's disease stage (Hoehn and Yahr scale) was 3.3 (SD=0.9), and all had Mini-Mental State Examination scores of 24 or higher. To identify specific regional patterns of brain metabolism associated with abnormal cognitive and mood functioning, the data were analyzed by using brain-behavior partial least squares. This multivariate voxel-based analysis allowed detection of significant topographic patterns of metabolic activity and quantification of the extent to which each topographic pattern correlated with scores on mnemonic, visuospatial, and dysphoric tests.
RESULTS: Two significant, independent topographic patterns were identified. Pattern 1 included parieto-occipito-temporal and medial temporal brain regions, and pattern 2 included the lateral frontal and anterior limbic cortex. Patterns 1 and 2 exhibited a double dissociation in their behavioral correlates: pattern 1 correlated with both visuospatial and mnemonic functioning but not with dysphoria; pattern 2 correlated with dysphoria but not with the cognitive measures.
CONCLUSIONS: The authors used the independence of topographic patterns and the size of correlations between topographic patterns and behavior to infer relationships among the pathophysiological processes responsible for the correlations. The finding that mildly abnormal mnemonic and visuospatial functioning correlated with the same topographic pattern suggests that a common pathophysiology underlies this marker of cognition in Parkinson's disease. By contrast, the independence of the two topographic patterns supports the notion that different mechanisms underlie cognitive and dysphoric symptoms in nondemented patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986127     DOI: 10.1176/appi.ajp.159.5.746

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  46 in total

Review 1.  Neuroimaging and cognition in Parkinson's disease dementia.

Authors:  Lisa C Silbert; Jeffrey Kaye
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

2.  Metabolic brain networks associated with cognitive function in Parkinson's disease.

Authors:  Chaorui Huang; Paul Mattis; Chengke Tang; Kenneth Perrine; Maren Carbon; David Eidelberg
Journal:  Neuroimage       Date:  2006-11-17       Impact factor: 6.556

Review 3.  The assessment of neurological systems with functional imaging.

Authors:  David Eidelberg
Journal:  Brain Lang       Date:  2006-08-08       Impact factor: 2.381

4.  Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.

Authors:  Daniel Weintraub; Donna Taraborelli; Knashawn H Morales; John E Duda; Ira R Katz; Matthew B Stern
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

5.  Assessment of disease progression in parkinsonism.

Authors:  Kotaro Asanuma; Vijay Dhawan; Maren Carbon; David Eidelberg
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

6.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

Review 7.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

8.  Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease.

Authors:  Gwenn S Smith; Kelly A Mills; Greg M Pontone; W Stanley Anderson; Kate M Perepezko; James Brasic; Yun Zhou; Jason Brandt; Christopher R Butson; Daniel P Holt; William B Mathews; Robert F Dannals; Dean F Wong; Zoltan Mari
Journal:  Parkinsonism Relat Disord       Date:  2019-04-16       Impact factor: 4.891

9.  Depression in Parkinson's disease. Diffusion tensor imaging study.

Authors:  Hideaki Matsui; Kazuto Nishinaka; Masaya Oda; Hidekazu Niikawa; Kenichi Komatsu; Tamotsu Kubori; Fukashi Udaka
Journal:  J Neurol       Date:  2006-08-20       Impact factor: 4.849

10.  Changes in network activity with the progression of Parkinson's disease.

Authors:  Chaorui Huang; Chengke Tang; Andrew Feigin; Martin Lesser; Yilong Ma; Michael Pourfar; Vijay Dhawan; David Eidelberg
Journal:  Brain       Date:  2007-04-30       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.